Compare ANEB & FOFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANEB | FOFO |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.8M | 85.2M |
| IPO Year | 2021 | 2025 |
| Metric | ANEB | FOFO |
|---|---|---|
| Price | $1.15 | $10.53 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 103.1K | 52.8K |
| Earning Date | 02-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,117,608.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $27.03 |
| Revenue Growth | N/A | ★ 1597.65 |
| 52 Week Low | $0.90 | $4.63 |
| 52 Week High | $3.42 | $68.00 |
| Indicator | ANEB | FOFO |
|---|---|---|
| Relative Strength Index (RSI) | 18.73 | N/A |
| Support Level | $1.14 | N/A |
| Resistance Level | $2.40 | N/A |
| Average True Range (ATR) | 0.19 | 0.00 |
| MACD | -0.12 | 0.00 |
| Stochastic Oscillator | 4.23 | 0.00 |
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
Hang Feng Technology Innovation Co Ltd is committed to providing comprehensive corporate management consulting and asset management services, tailored to address the specific needs of each client. Its goal is to empower its clients to design, implement, and achieve their unique business and investment objectives. Its business consists of two main segments: (i) corporate management consulting services and (ii) asset management services. The corporate management consulting services include Management consulting, and Regulatory compliance and governance consulting.